Zdeněk Adam
- Hematology top 2%
- Multiple Myeloma Research and Treatments 24
- Oncology top 10%
- Cancer Treatment and Pharmacology 7
- Peptidase Inhibition and Analysis 6
- Genetics top 10%
-
- Protein Degradation and Inhibitors 4
- Cancer therapeutics and mechanisms 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 4
- Glycosylation and Glycoproteins Research 2
-
- Peripheral Neuropathies and Disorders 2
- Co-authors
- Roman HájekMarta KrejčíLuděk PourHeinz LudwigViera SandeckáRichard GreilNiklas ZojerPetr Kuglík
- Cited by
- HematologyOncologyGenetics
In The Last Decade
Zdeněk Adam
27 papers receiving 574 citations
Peers
Comparison fields: 5 of 49
- Hematology 521
- Oncology 313
- Genetics 81
- Molecular Biology 418
- Pathology and Forensic Medicine 43
Countries citing papers authored by Zdeněk Adam
This map shows the geographic impact of Zdeněk Adam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zdeněk Adam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zdeněk Adam more than expected).
Fields of papers citing papers by Zdeněk Adam
This network shows the impact of papers produced by Zdeněk Adam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zdeněk Adam. The network helps show where Zdeněk Adam may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zdeněk Adam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 3 | |
| 5 | 2019 | 4 | |
| 6 | 2018 | 4 | |
| 7 | 2015 | 18 | |
| 8 | 2014 | 1 | |
| 9 | 2013 | 124 | |
| 10 | 2013 | 5 | |
| 11 | 2011 | 5 | |
| 12 | 2009 | 54 | |
| 13 | 2009 | 18 | |
| 14 | 2009 | 0 | |
| 15 | 2009 | 10 | |
| 16 | 2008 | 148 | |
| 17 | 2005 | 4 | |
| 18 | 2004 | 33 | |
| 19 | The therapy of anemia in patients with multiple myeloma | 1995 | 1 |
| 20 | Therapy of anemia in patients with multiple myeloma. | 1995 | 2 |
About Zdeněk Adam
Zdeněk Adam is a scholar working on Hematology, Oncology and Occupational Therapy, having authored 30 papers that have together received 586 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (24 papers), Cancer Treatment and Pharmacology (7 papers), Peptidase Inhibition and Analysis (6 papers), Protein Degradation and Inhibitors (4 papers), Cancer therapeutics and mechanisms (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Peripheral Neuropathies and Disorders (2 papers). The work is most often cited by research in Hematology (521 citations), Oncology (313 citations) and Genetics (81 citations). Zdeněk Adam has collaborated with scholars based in Czechia, Austria and Croatia. Frequent co-authors include Roman Hájek, Marta Krejčí, Luděk Pour, Heinz Ludwig, Viera Sandecká, Richard Greil, Niklas Zojer, Petr Kuglík, Henrieta Grešlíková and Ivan Špıčka. Their work appears in journals such as Blood, PLoS ONE and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.